R-CHOP VS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN: FIRST RESULTS OF MRD ASSESSMENT WITHIN THE RANDOMIZED TRIAL FOR ELDERLY PATIENTS WITH MCL